These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 22796160)

  • 1. A review of nanocarriers for the delivery of small interfering RNA.
    Kesharwani P; Gajbhiye V; Jain NK
    Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.
    Zhao J; Feng SS
    Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA.
    Liu B
    Brief Funct Genomic Proteomic; 2007 Jun; 6(2):112-9. PubMed ID: 17670766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
    Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
    FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA delivery systems for cancer treatment.
    Oh YK; Park TG
    Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo delivery of RNAi with lipid-based nanoparticles.
    Huang L; Liu Y
    Annu Rev Biomed Eng; 2011 Aug; 13():507-30. PubMed ID: 21639780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SiRNA delivery: challenges and role of carrier systems.
    Shegokar R; Al Shaal L; Mishra PR
    Pharmazie; 2011 May; 66(5):313-8. PubMed ID: 21699063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla.
    Meade BR; Dowdy SF
    Discov Med; 2009 Dec; 8(43):253-6. PubMed ID: 20040280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of small interfering RNA: approaching effective cancer therapies.
    Pirollo KF; Chang EH
    Cancer Res; 2008 Mar; 68(5):1247-50. PubMed ID: 18316585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research progress on the development of the strategies for siRNAs delivery in vivo].
    Tang D; Mao A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin-targeted stabilized nanoparticles for an efficient delivery of siRNAs in vitro and in vivo.
    Srinivasan C; Peer D; Shimaoka M
    Methods Mol Biol; 2012; 820():105-16. PubMed ID: 22131028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly efficient siRNA delivery system into human and murine cells using single-wall carbon nanotubes.
    Ladeira MS; Andrade VA; Gomes ER; Aguiar CJ; Moraes ER; Soares JS; Silva EE; Lacerda RG; Ladeira LO; Jorio A; Lima P; Leite MF; Resende RR; Guatimosim S
    Nanotechnology; 2010 Sep; 21(38):385101. PubMed ID: 20798464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonendocytic delivery of lipoplex nanoparticles into living cells using nanochannel electroporation.
    Boukany PE; Wu Y; Zhao X; Kwak KJ; Glazer PJ; Leong K; Lee LJ
    Adv Healthc Mater; 2014 May; 3(5):682-9. PubMed ID: 23996973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocarriers: a tool to overcome biological barriers in siRNA delivery.
    Kumari A; Kumar V; Yadav SK
    Expert Opin Biol Ther; 2011 Oct; 11(10):1327-39. PubMed ID: 21682658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.
    Iyer AK; Duan Z; Amiji MM
    Mol Pharm; 2014 Aug; 11(8):2511-26. PubMed ID: 24661041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarrier Mediated siRNA Delivery Targeting Stem Cell Differentiation.
    Fernandes F; Kotharkar P; Chakravorty A; Kowshik M; Talukdar I
    Curr Stem Cell Res Ther; 2020; 15(2):155-172. PubMed ID: 31789134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.